Related Experiment Videos
Design and development of adjuvant-active nonionic block copolymers
M J Newman1, C W Todd, M Balusubramanian
1Vaxcel, Inc., 154 Technology Parkway, Norcross, Georgia 30092 and CytRx Corporation, 154 Technology Parkway, Norcross, Georgia 30092, USA. newmanm@cytrx.com
Journal of Pharmaceutical Sciences
|November 13, 1998
Summary
Novel nonionic block copolymers act as effective vaccine adjuvants. Tailoring poly(oxyethylene) content customizes immune responses, enhancing vaccine efficacy for specific pathogen types.
Area of Science:
- Polymer Chemistry
- Immunology
- Vaccine Development
Background:
- Nonionic block copolymers, synthesized from propylene oxide and ethylene oxide, possess unique vaccine adjuvant properties.
- These copolymers can be engineered with specific molecular weights and poly(oxyethylene) (POE) content to modulate their self-assembly and immune-stimulating capabilities.
Purpose of the Study:
- To design and produce nonionic block copolymers with tailored adjuvant properties.
- To investigate the influence of copolymer size and POE content on self-assembly into microparticles and subsequent vaccine adjuvant activity.
- To determine how varying POE content affects the type of immune response (Type 1 vs. Type 2 helper T-lymphocyte responses).
Main Methods:
- Synthesis of nonionic block copolymers with high molecular weight poly(oxypropylene) (POP) cores and varying POE end blocks.
- Characterization of copolymer self-assembly into micelles and microparticles in aqueous solutions.
- Formulation of protein-adjuvant complexes and evaluation of adjuvant activity.
- Assessment of immune responses, specifically Type 1 and Type 2 helper T-lymphocyte responses, mediated by different copolymer formulations.
Main Results:
- Nonionic block copolymers with <10% POE spontaneously form 300 nm-3 µm microparticles in aqueous solutions.
- Maximal adjuvant activity was observed with low POE content (5-10%) and molecular sizes of 11-12 kDa.
- Copolymers with 10% POE preferentially augmented Type 2 helper T-lymphocyte responses.
- Copolymers with lower POE content (<10%) augmented both Type 1 and Type 2 helper T-lymphocyte responses.
Conclusions:
- Nonionic block copolymers serve as effective, customizable vaccine adjuvants.
- The poly(oxyethylene) content is a critical factor in determining both the magnitude and type of immune response elicited.
- These findings enable the development of vaccines with precisely tailored immune-stimulating profiles for optimal efficacy against specific pathogens.